Affinity chromatography is undoubtedly the most potent way to separate one active compound from its environment. Compared to a multi-step process, one unique capture step allows to reduce time and costs, along with decreasing the risks in the process scale-up. With Affichrom’, Affilogic proposes the development of tailor-made affinity chromatography columns for purification of biologics such as recombinant proteins, blood products, vaccines, particles and antibody fragments.
We repeatedly demonstrated with our Pharma partners that the number of downstream purification steps can be drastically reduced in a real-life industrial production process centered on affinity purification, providing higher overall purity and even up to doubling final yield.
We are now opening our platform to propose custom separation processes based on the Nanofitins® technology. The aim is to tackle technical and performance issues of our partners and obtain higher purification yields at affordable costs.
Virtually meet us at BIO-Europe Spring Digital
March 28-31, 2022
Meet us at Bioprocessing Summit Europe 2022 in Barcelona
March 22-24, 2022
Our R&D Project Manager Anne Chevrel will present in Stream #2 “Advances in Recovery and Purification” on March 22nd, 9:30am
Nanofitins® bear all ligands features to promote affinity chromatography for purification of most biologics.Read More
Affilogic tackles technical and performance issues to obtain higher purification yields at affordable costs .Read More
Affilogic proposes the development of tailor-made affinity chromatography columns.Read More